ArticleOncology letters2021

Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma.

Ji Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.